| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | INTREXON CORP | 62,169,071 | 1,510,708,000 | 81.42% | ||
| 2 | HALOZYME THERAPEUTICS INC | 19,305,403 | 190,737,000 | 10.28% | ||
| 3 | ZIOPHARM ONCOLOGY INC | 9,709,607 | 51,946,000 | 2.80% | ||
| 4 | ENTERPRISE PRODS PARTNERS L | 1,035,834 | 28,009,000 | 1.51% | ||
| 5 | ENERGY TRANSFER L P | 752,400 | 14,529,000 | 0.78% | ||
| 6 | FIBROCELL SCIENCE INC | 16,620,414 | 10,470,000 | 0.56% | ||
| 7 | SYNTHETIC BIOLOGICS INC | 13,238,268 | 10,095,000 | 0.54% | ||
| 8 | ORAGENICS INC COM NEW | 15,481,644 | 8,360,000 | 0.45% | ||
| 9 | GENESIS ENERGY LP COM UNITS NPV | 217,000 | 7,816,000 | 0.42% | ||
| 10 | NUSTAR ENERGY LP | 116,500 | 5,802,000 | 0.31% | ||
| 11 | TC PIPELINES LP | 97,000 | 5,707,000 | 0.31% | ||
| 12 | HISTOGENICS CORP | 2,690,570 | 4,493,000 | 0.24% | ||
| 13 | ENERGY TRANSFER PRTNRS L P | 85,135 | 3,049,000 | 0.16% | ||
| 14 | TRANSGENOMIC INC | 7,550,669 | 2,146,000 | 0.12% | ||
| 15 | SOLIGENIX INC | 436,783 | 983,000 | 0.05% | ||
| 16 | OVASCIENCE INC COM | 373,224 | 571,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-17-004281, filed 2017.02.03).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
